共 21 条
IMPLANTATION OF A CARDIAC CONTRACTILITY MODULATOR IN CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: RESULTS OF A 6-MONTH FOLLOW-UP OF ONE HUNDRED PATIENTS
被引:1
作者:
Uskach, T. M.
[1
,2
]
Sapelnikov, O., V
[1
]
Safiullina, A. A.
[1
]
Grishin, I. R.
[1
]
Amanatova, V. A.
[1
]
Akchurin, R. S.
[1
]
Tereshchenko, S. N.
[1
,2
]
机构:
[1] Natl Med Res Ctr Cardiol, Moscow, Russia
[2] Russian Med Acad Continuous Profess Educ, Moscow, Russia
来源:
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV
|
2021年
/
23卷
/
01期
关键词:
heart failure;
atrial fibrillation;
modulation of heart contractility;
left ventricular ejection;
fraction;
quality of life;
D O I:
10.15825/1995-1191-2021-1-30-37
中图分类号:
R3 [基础医学];
R4 [临床医学];
学科分类号:
1001 ;
1002 ;
100602 ;
摘要:
Aim: to study the effect of cardiac contractility modulation (CCM) in patients with chronic heart failure (CHF) and atrial fibrillation (AF). Materials and methods. In a group of 100 patients with CHF and AF, the following studies were performed before implantation of the CCM and after 6 months of follow-up: 12-channel ECG, transthoracic Echocardiography, 6-minute walk test, determination of the level of pro-natriuretic N-terminal peptide (NT-proBNP), and a questionnaire based on the Minnesota quality of life questionnaire for patients with CHF (MHFLQ). All patients received long-term optimal medication therapy for CHF before surgery. Results. The results show a positive effect of the use of MCC in patients with CHF and AF on reverse LV remodeling, functional class of CHF, and levels of NT-pro-BNP regardless of the form of AF. Conclusion. The use of MCC may be a promising treatment method in addition to optimal medication therapy in patients with CHF and AF.
引用
收藏
页码:30 / 37
页数:8
相关论文